Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Joint Venture On The Rocks? Schering Looks To Compete With Partner Merck

Executive Summary

Schering-Plough is exploring opportunities to add Zetia (ezetimibe) to an agent that would give the treatment an entrance into the growing HDL-cholesterol category

You may also be interested in...



Schering Tries To Lower Merck HDL Agent Expectations, Without Razing JV

Schering-Plough is downplaying the potential impact of Merck's investigational niacin products on its cholesterol agents Zetia and Vytorin, which the firm markets through a joint venture with Merck

Schering Tries To Lower Merck HDL Agent Expectations, Without Razing JV

Schering-Plough is downplaying the potential impact of Merck's investigational niacin products on its cholesterol agents Zetia and Vytorin, which the firm markets through a joint venture with Merck

Merck delays Zocor/niacin combo

Merck will not file its fixed-dose combo drug MK-0524B, combining Zocor (simvastatin) and MK-0524A (extended-release niacin and a flushing inhibitor), in 2007 as planned due to formulation problems, the company announces Sept. 29. The company will continue its late-stage clinical program to support the regulatory filing for the LDL-lowering/HDL-raising triple combination, but it did not announce a new timeline for NDA submission. The firm still expects to file MK-0524A in 2007. Merck has continuously said that neither product will affect Vytorin (simvastatin/ezetimibe), which it co-markets with Schering-Plough (1"The Pink Sheet" Jan. 16, 2006, p. 12)...

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS046759

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel